Who should get RSV preventive medicine?
Because these injections are expensive, the Committee on Infectious Diseases of the American Academy of Pediatrics has devised guidelines on which infants should get this RSV preventive medicine. Here are the general guidelines: [UNORDERED_LIST {“All premature infants under 32 weeks of age at the start of the RSV season” “All infants under two years of age with chronic lung disease” “All infants under two years of age with certain types of congenital heart disease” “All infants under two years of age with compromised pulmonary or immune function”}] Infants between 32 and 35 weeks of age at the start of the RSV season are in a sort of in a gray zone in which additional risk factors may make them candidates for these injections. This is the group your babies fit into. Infants between 32 and 35 weeks with the following risk factors should receive the RSV preventive-medicine injections: [UNORDERED_LIST {“Infants in daycare” “Twins or multiple births” “Infants who are exposed to tobacco smo